- Public Comps
- Luxempart
Luxempart Valuation Multiples
Discover Luxempart's revenue and EBITDA valuation multiples, acquisitions, and investment history, alongside public comparables like AFP ProVida, IntegraFin, Eurocommercial Properties, Australian United Investment Company and more.
Luxempart Overview
About Luxempart
Luxempart SA is an investment company that invests in a portfolio of listed and non-listed companies. The firm makes investments that vary from long-term to medium-term, with the majority of investments being in the long term. The company has two business segments; Direct Investments consist of taking direct participation in companies in the target geographical regions, which consist of the Benelux region (Belgium, Luxembourg), France, DACH region (Germany, Austria, Switzerland), and Italy, and The Investment Funds consists in the acquisition of shares in Investment Funds mainly active in private equity and venture capital.
Founded
1988
HQ

Employees
28
Website
Sectors
Financials (FY)
EV
$1.7B
Valuation Multiples
Start free trialLuxempart Financials
Luxempart reported last fiscal year revenue of $327M.
In the same fiscal year, Luxempart generated $305M in net income.
Luxempart P&L
In the most recent fiscal year, Luxempart reported revenue of $327M and net income of $305M.
Luxempart is profitable as of last fiscal year, with net margin of 93%.
Financial data powered by Morningstar, Inc.
Luxempart Stock Performance
Luxempart has current market cap of $1.8B, and enterprise value of $1.7B.
Market Cap Evolution
Luxempart's stock price is $87.06.
Luxempart share price decreased by 0.1% in the last 30 days, and increased by 9.7% in the last year.
Luxempart has an EPS (earnings per share) of $15.13.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1.7B | $1.8B | -0.1% | -0.1% | 4.5% | 9.7% | $15.13 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialLuxempart Valuation Multiples
Luxempart trades at 5.1x EV/Revenue multiple.
Luxempart Financial Valuation Multiples
As of August 25, 2026, Luxempart has market cap of $1.8B and EV of $1.7B.
Luxempart has a P/E ratio of 5.8x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Luxempart Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Luxempart Margins & Growth Rates
In the most recent fiscal year, Luxempart reported net margin of 93%.
Luxempart Margins
Luxempart Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Luxempart Operational KPIs
Luxempart's revenue per employee in the last FY averaged $11.7M, while opex per employee averaged $0.3M for the same period.
Data powered by FactSet, Inc. and Morningstar, Inc.
Luxempart Competitors
Luxempart competitors include AFP ProVida, IntegraFin, Eurocommercial Properties, Australian United Investment Company, FII Ancar IC, Tamburi Inv Partners, Montea, Icade, Metrics Master Income and Deterra Royalties.
Most Luxempart public comparables operate across Asset Management.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 4.7x | - | 7.3x | - | |||
| 7.3x | 6.6x | 11.7x | 14.3x | |||
| 10.9x | 13.0x | 11.4x | 16.0x | |||
| 48.6x | - | - | - | |||
| - | - | - | - | |||
| 164.1x | 721.9x | 28.2x | (96.2x) | |||
| 9.3x | 10.3x | 7.9x | 10.6x | |||
| 3.5x | 14.8x | (96.4x) | 16.1x | |||
This data is available for Pro users. Sign up to see all Luxempart competitors and their valuation data. Start Free Trial | ||||||
Acquisitions by Luxempart
Luxempart has acquired 12 companies to date.
Last acquisition by Luxempart was on December 16th 2025. Luxempart acquired VALEARA for undisclosed valuation.
Latest Acquisitions by Luxempart
| Description | VALEARA is a Germany-based provider of specialized care for psychiatric, neurological conditions, and physiotherapy services. | Assmann is a German supplier of server, network and peripheral infrastructure products. The group sources components directly in Asia and distributes across Europe, mainly through resellers and distributors rather than end customers. Assmann covers connectivity, cabinets, power and workplace peripherals for IT installers and integrators. | Nexus AG is a Germany-headquartered healthcare IT provider operating in 23 European countries and the Middle East. The company develops software for hospitals, rehabilitation centers, and senior care facilities focused on medical documentation and information management. Nexus AG delivers modular applications that integrate patient data across departments for streamlined clinical processes. | Rimed is a Swiss diagnostic radiology group running a network of imaging centres across the German- and Italian-speaking cantons. The business covers general radiology as well as interventional procedures, serving referring physicians and hospitals on an outpatient basis. Rimed bills payers and patients for imaging examinations performed at its sites. | |
| HQ Country | |||||
| HQ City | - | Ludenscheid | Donaueschingen | Zug | |
| Deal Date | 16 Dec 2025 | 5 Dec 2025 | 5 Nov 2024 | 3 Nov 2022 | |
| Valuation | undisclosed | undisclosed | $1.3B | undisclosed | |
| EV/Revenue | |||||
| EV/EBITDA | |||||
This data is available for Pro users. Sign up to see all Luxempart acquisitions and their M&A valuation multiples. Start Free Trial | |||||
Investments by Luxempart
Luxempart has invested in 11 companies to date.
Latest investment by Luxempart was on June 20th 2024. Luxempart invested in Medios in their Secondary round.
Latest Investments by Luxempart
| Description | Medios AG is engaged as a wholesaler for pharmaceutical medicinal products. The operating segments of the company includes: Patient-Specific Therapies: This area includes the compounding of medications on behalf of pharmacies in Germany. Pharmaceautical Supply: Medios is speciality pharma supplier company in germany, producing it own production facilities, hospitals, and Pharmacies. International Business: It includes all business and activities happening in international business. | alphacaps is a German contract developer and manufacturer of nutritional supplements. The company formulates and produces supplements on behalf of brand owners across a wide span of dosage formats, backed by the certifications required for food supplement production. Revenue comes from manufacturing contracts rather than own-brand sales. | Coutot-Roehrig is a probate research firm that traces and identifies heirs in estates left without known beneficiaries. Notaries and other legal officers appoint the company to establish entitlement and see estates through to settlement. The business works from a proprietary archive of digitised records covering more than a billion data points, backed by 46 branch offices in France, Spain, Italy, Belgium, Luxembourg, Switzerland, Monaco and the United States, plus a correspondent network reaching further afield. Coutot-Roehrig has traded since 1894 and reported revenues above EUR 70 million in 2022. | Kestrel Vision is a machine vision group serving the container inspection market. The company designs its own inspection systems and outsources their manufacture, running a fabless model, and sells them with data collection, analytics and support services attached. Its equipment checks the production and filling of rigid containers, mainly for food and beverage customers and to a smaller degree for pharmaceutical producers. Kestrel Vision started in glass packaging and has moved into plastic and metal packaging through acquisitions, with around two thirds of sales made outside Europe. | |
| HQ Country | |||||
| HQ City | Berlin | Augustdorf | Paris | Saint-Genis-Laval | |
| Deal Date | 20 Jun 2024 | 30 Oct 2023 | 19 Apr 2023 | 6 Feb 2023 | |
| Round | Secondary | Undisclosed stage | Undisclosed stage | Undisclosed stage | |
| Raised | undisclosed | undisclosed | undisclosed | undisclosed | |
| Investors | Luxempart | Luxempart | Luxempart | Luxempart; Caravelle SA | |
| Valuation | undisclosed | undisclosed | undisclosed | undisclosed | |
| EV/Revenue | |||||
| EV/EBITDA | |||||
This data is available for Pro users. Sign up to see all Luxempart investments and their VC round multiples. Start Free Trial | |||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Luxempart
| When was Luxempart founded? | Luxempart was founded in 1988. |
| Where is Luxempart headquartered? | Luxempart is headquartered in Luxembourg. |
| How many employees does Luxempart have? | As of today, Luxempart has over 28 employees. |
| Is Luxempart publicly listed? | Yes, Luxempart is a public company listed on Luxembourg Stock Exchange. |
| What is the stock symbol of Luxempart? | Luxempart trades under LXMPR ticker. |
| When did Luxempart go public? | Luxempart went public in 1988. |
| Who are competitors of Luxempart? | Luxempart main competitors include AFP ProVida, IntegraFin, Eurocommercial Properties, Australian United Investment Company, FII Ancar IC, Tamburi Inv Partners, Montea, Icade, Metrics Master Income, Deterra Royalties. |
| What is the current market cap of Luxempart? | Luxempart's current market cap is $1.8B. |
| What is the current revenue of Luxempart? | Luxempart's last fiscal year revenue is $327M. |
| What is the current EV/Revenue multiple of Luxempart? | Current revenue multiple of Luxempart is 5.1x. |
| Is Luxempart profitable? | No, Luxempart is not profitable. |
| How many companies Luxempart has acquired to date? | As of August 2026, Luxempart has acquired 10 companies. |
| What was the largest acquisition by Luxempart? | $4B acquisition of Zooplus on 13th August 2021 was the largest M&A Luxempart has done to date. |
| What companies Luxempart acquired? | Luxempart acquired Zooplus, Nexus AG, Schaltbau Holding, VALEARA, Novotergum, Tonies, Assmann, Rattay, Baobab Collection, and Rimed. |
| In how many companies Luxempart has invested to date? | As of August 2026, Luxempart has invested in 11 companies. |
| What was the last Luxempart investment? | On 20th June 2024 Luxempart invested in Medios, participating in a Secondary round. |
See public comps similar to Luxempart
Lists including Luxempart
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.







